Designation granted under Innovative Licensing and Access Pathway which aims to accelerate development of, and access to, transformative new medicines in the United Kingdom Designation granted under Innovative Licensing and Access Pathway which aims to accelerate development of, and access to, transformative new medicines in the United Kingdom
Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA
Source: GlobeNewsWire